Experienced in Giant Papillary Conjunctivitis

Dr. Leonard B. Bacharier

Pediatric Allergy and Immunology | Pediatrics | Allergy and Immunology
3601 The Vanderbilt Clinic, 
Nashville, TN 
Accepting New Patients
Offers Telehealth
Experienced in Giant Papillary Conjunctivitis
3601 The Vanderbilt Clinic, 
Nashville, TN 
OverviewInsuranceLocationsClinical Research

Overview

Leonard Bacharier is a Pediatric Allergy and Immunologist and a Pediatrics provider in Nashville, Tennessee. Dr. Bacharier is rated as an Experienced provider by MediFind in the treatment of Giant Papillary Conjunctivitis. His top areas of expertise are Asthma, Stridor, Asthma in Children, and Eosinophilic Asthma. Dr. Bacharier is currently accepting new patients.

His clinical research consists of co-authoring 314 peer reviewed articles and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Giant Papillary Conjunctivitis.

Specialties
Pediatric Allergy and Immunology
Pediatrics
Allergy and Immunology
Licenses
Pediatrics in MO
Languages Spoken
English
French
Spanish
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alliant Health
  • HMO
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
View 4 Less Insurance Carriers -

Locations

3601 The Vanderbilt Clinic, Nashville, TN 37232

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

Childhood Allergy and the Neonatal Environment
Childhood Allergy and the Neonatal Environment
Enrollment Status: Active_not_recruiting
Publish Date: August 21, 2025
Urban Environment and Childhood Asthma (URECA)
Urban Environment and Childhood Asthma (URECA)
Enrollment Status: Completed
Publish Date: July 18, 2025
PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network Study
PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network Study
Enrollment Status: Completed
Publish Date: June 19, 2025
Intervention Type: Drug, Other
Study Drugs: Medium Chain Triglycerides, Clazakizumab, Broncho-Vaxom, Imatinib, Cavosonstat, Itacitinib
Study Phase: Phase 2
Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy, Safety and Tolerability of ORal Bacterial EXtract for the Prevention of Wheezing Lower Respiratory Tract Illness (ORBEX)
Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy, Safety and Tolerability of ORal Bacterial EXtract for the Prevention of Wheezing Lower Respiratory Tract Illness (ORBEX)
Enrollment Status: Active_not_recruiting
Publish Date: August 29, 2024
Intervention Type: Other, Drug
Study Drug: Broncho-Vaxom
Study Phase: Phase 2
Children's Respiratory and Environmental Workgroup (CREW)02
Children's Respiratory and Environmental Workgroup (CREW)02
Enrollment Status: Completed
Publish Date: August 14, 2023
Cockroach Immunotherapy in Children and Adolescents
Cockroach Immunotherapy in Children and Adolescents
Enrollment Status: Completed
Publish Date: May 22, 2023
Intervention Type: Biological
Study Drug: Blattella germanica Allergenic Extract
Study Phase: Phase 2
Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy: A Systems Approach Phase 2 (ICAC-30)
Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy: A Systems Approach Phase 2 (ICAC-30)
Enrollment Status: Completed
Publish Date: July 20, 2022
Intervention Type: Drug, Biological
Study Phase: Phase 2
Vitamin D to Prevent Severe Asthma Exacerbations
Vitamin D to Prevent Severe Asthma Exacerbations
Enrollment Status: Terminated
Publish Date: August 12, 2021
Intervention Type: Drug
Study Phase: Phase 2
Registry for Asthma Characterization and Recruitment 2 (ICAC-25)
Registry for Asthma Characterization and Recruitment 2 (ICAC-25)
Enrollment Status: Completed
Publish Date: January 25, 2021
Severe Asthma Research Program (SARP)-Washington University
Severe Asthma Research Program (SARP)-Washington University
Enrollment Status: Unknown
Publish Date: October 06, 2020
Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy: A Systems Approach Phase 1 (ICAC-29)
Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy: A Systems Approach Phase 1 (ICAC-29)
Enrollment Status: Completed
Publish Date: February 20, 2018
View 10 Less Clinical Trials

314 Total Publications

Cumulative Genetic Risk for Asthma Contributes to Disease Severity in Children with Asthma living in Urban Environments.
Cumulative Genetic Risk for Asthma Contributes to Disease Severity in Children with Asthma living in Urban Environments.
Journal: medRxiv : the preprint server for health sciences
Published: September 18, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Bacharier's expertise for a condition
ConditionClose
View All 10 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile